111 related articles for article (PubMed ID: 8853)
1. [Comparison of the sedative effects of 2 alpha-sympathomimetic antihypertensive agents: clonidine and tiamenidine].
Simon P; Chermat R; Boissier JR
Therapie; 1975; 30(6):855-61. PubMed ID: 8853
[No Abstract] [Full Text] [Related]
2. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
Seidel WF; Maze M; Dement WC; Edgar DM
J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.
Clough DP; Hatton R
Br J Pharmacol; 1981 Jul; 73(3):595-604. PubMed ID: 6113864
[TBL] [Abstract][Full Text] [Related]
4. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
Findlay D; Lawrence JR
Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.
Ruffolo RR; Yaden EL; Timmermans PB; van Zwieten PA; Hynes MD
J Pharmacol Exp Ther; 1984 Apr; 229(1):58-66. PubMed ID: 6323690
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evidence for the involvement of alpha-2 adrenoceptors in the sedative effect of detomidine, a novel sedative-analgesic.
Virtanen R; Ruskoaho H; Nyman L
J Vet Pharmacol Ther; 1985 Mar; 8(1):30-7. PubMed ID: 2859378
[TBL] [Abstract][Full Text] [Related]
7. [Adrenergic receptor and alpha 2 agonist--4: Applied and clinical pharmacology of alpha 2 agonist].
Mizobe T
Masui; 1997 Aug; 46(8):1066-70. PubMed ID: 9283162
[TBL] [Abstract][Full Text] [Related]
8. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.
Millan MJ; Lejeune F; Gobert A; Brocco M; Auclair A; Bosc C; Rivet JM; Lacoste JM; Cordi A; Dekeyne A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1206-22. PubMed ID: 11082458
[TBL] [Abstract][Full Text] [Related]
9. [Experimental analysis of interference between alpha-adrenergic stimulants with anti-hypertensive activity and the narcotic activity of pentobarbital].
Caputi AP; Russo G; Scafuro MA; Turtur A; Lampa E; Sannino A; Nunziata A
Arch Sci Med (Torino); 1978; 135(3):351-8. PubMed ID: 30418
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to a new class of non-benzodiazepine anxiolytics.
Chodera A; Nowakowska E; Bartczak G
Pol J Pharmacol; 1994; 46(5):479-81. PubMed ID: 7894538
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic and hemodynamic effects of chronic oral therapy with the alpha 2-agonists clonidine and tiamenidine in hypertensive volunteers.
Roden DM; Nadeau JH; Primm RK
Clin Pharmacol Ther; 1988 Jun; 43(6):648-54. PubMed ID: 2897889
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
[TBL] [Abstract][Full Text] [Related]
13. The effect of clonidine and related substances on voluntary ethanol consumption in rats.
Opitz K
Drug Alcohol Depend; 1990 Feb; 25(1):43-8. PubMed ID: 1969792
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of detomidine and other alpha 2-adrenoceptor agonists in the brain.
Virtanen R
Acta Vet Scand Suppl; 1986; 82():35-46. PubMed ID: 2876607
[No Abstract] [Full Text] [Related]
15. Antidiarrheal activity of alpha-2 adrenoceptor agonist SK&F 35886.
Fondacaro JD; McCafferty GP; Kolpak DC; Smith PL
J Pharmacol Exp Ther; 1989 Apr; 249(1):221-8. PubMed ID: 2565389
[TBL] [Abstract][Full Text] [Related]
16. Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype.
Galeotti N; Bartolini A; Ghelardini C
Behav Brain Res; 2004 Aug; 153(2):409-17. PubMed ID: 15265636
[TBL] [Abstract][Full Text] [Related]
17. [Psychopharmacologic profile of prazepam].
Boissier JR; Zebrowska-Lupina I; Simon P
Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):330-44. PubMed ID: 5062440
[No Abstract] [Full Text] [Related]
18. [Platelet aggregation and antihypertensive alpha-adrenergic agonists].
Imperatore A; Vairo G; Lampa E; Sasso M; Ottavo R; Scognamiglio R
Arch Sci Med (Torino); 1980; 137(2):241-6. PubMed ID: 6111990
[TBL] [Abstract][Full Text] [Related]
19. [Role of alpha-sympathomimetic agents in the central nervous system. Study of the central effects of adrenergic drugs by injection into the vertebral artery].
Van Zwieten PA
Therapie; 1972; 27(4):565-75. PubMed ID: 4404301
[No Abstract] [Full Text] [Related]
20. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
